Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | RGCRegencell Bioscience Holdings LtdFY2026 · Jun |
|---|---|
| Revenue | — |
| Revenue, yoy | — |
| Net income | $11.70M |
| Net income, yoy | −226.5% |
| Net margin | — |
| Free cash flow | $3.27M |
| FCF margin | — |
| EPS, diluted | $2.37 |
Add another company.
No annual figures on file for this.